通过体外血清反向试验确诊的一例IV型日光性荨麻疹病例。

A case of type IV solar urticaria identified by reverse in vitro serum test.

作者信息

Ozaki Hirotake, Matsuyama Takashi, Kawakubo Yo, Miyahara Motomi, Ozawa Akira

机构信息

Department of Dermatology, Tokai University School of Medicine, Isehara, Kanagawa, Japan.

出版信息

Tokai J Exp Clin Med. 2003 Jul;28(2):51-5.

PMID:14714829

Abstract

We had a 17-year-old male patient with solar urticaria diagnosed as type IV of modified Harber's classification. The action spectrum of this case was estimated to be 433-499 nm and the inhibition spectrum was 533 nm. Both in vitro serum test and tentatively designated "reverse in vitro serum test" were positive. The patient was prescribed 20 mg/day epinastine hydrochloride (Alesion) orally for 49 weeks with improvement of the symptoms.

摘要

我们有一名17岁的男性日光性荨麻疹患者，根据改良的哈伯分类法被诊断为IV型。该病例的作用光谱估计为433 - 499纳米，抑制光谱为533纳米。体外血清试验和初步命名为“反向体外血清试验”均呈阳性。患者口服盐酸依匹斯汀（阿乐仙）20毫克/天，持续49周，症状有所改善。